期刊文献+

罗格列酮对人胃癌细胞系迁移侵袭的抑制及其机制 被引量:6

Rosiglitazone inhibits cell invasion and metastasis in human gastric cancer cell lines SGC7901 and SGC7901/VCR
下载PDF
导出
摘要 目的:探讨罗格列酮对人胃癌SGC7901、SGC7901/VCR细胞侵袭转移能力及LIMK1基因蛋白表达的影响.方法:罗格列酮(40mg/L)作用SGC7901和SGC7901/VCR细胞24h后,采用划痕实验和Transwell实验分别观察罗格列酮对细胞的迁移和侵袭能力.RT-PCR检测LIMK1mRNA和cofilin-1mRNA的表达情况;Westernblot检测LIMK1和p-cofilin-1的蛋白表达.结果:结果显示,40mg/L罗格列酮分别作用SGC7901细胞和SGC7901/VCR细胞24h后,细胞的迁移和侵袭能力均被罗格列酮抑制(P<0.05).RT-PCR结果显示LIMK1mRNA水平明显下降(P<0.05),cofilin-1无明显影响(P>0.05).Westernblot检测显示罗格列酮作用SGC7901细胞和SGC7901/VCR细胞24h后,LIMK1和p-cofilin-1蛋白的表达水平下降(P<0.05).结论:罗格列酮可抑制人胃癌SGC7901和SGC7901/VCR细胞迁移与侵袭能力;罗格列酮抗肿瘤细胞迁移与侵袭的机制可能与其下调LIMK1进而抑制cofilin-1的激活相关. AIM: To investigate the effect of rosiglitazone (ROS) on cell invasion and metastasis in human gastric cancer cell lines SGC7901 and SGC7901/ VCR and to explore possible mechanisms in- volved. METHODS: Wound healing assay and in vitro invasion assay were used to investigate the an- tirnetastatic activities of ROS in SGC7901 and SGC7901/VCR cells. After treating SGC7901 and SGC7901/VCR cells with ROS (40 μmol/L) for 24 h, the mRNA levels of LIMK1 and cofilin-1 were assessed by reverse transcription-poly-rnerase chain reaction (RT-PCR), and the protein levels of LIMK1, cofilint and p-cofilin-1 were assessed by Western blot. RESULTS: Treatment with ROS at a concen- tration of 40μmol/L for 24 h significantly in- hibited cellular invasion and metastasis (P 〈 0.05), down-regulated the expression of LIMK1 mRNA and protein and the level of p-cofilin-1 (all P 〈 0.05) but showed no significant impact on cofilin-l-1 rnRNA level (P 〉 0.05). CONCLUSION: ROS elicited a significant inhi- bition of in vitro cell migration and invasion in human gastric cancer cell lines SGC7901 and SGC7901/VCR possibly by down-regulating the expression of LIMK1 and inhibiting cofilin-1 ac- tivation.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第21期2207-2213,共7页 World Chinese Journal of Digestology
关键词 罗格列酮 迁移 侵袭 LIMK1 Cofilin-1 Rosiglitazone Motility Invasion LIMKI Cofllin-i
  • 相关文献

参考文献29

  • 1Shimada T, Hiraishi H. [PPARgamma agonists for the diseases of gastrointestinal tract and liver]. Nippon Rinsho 2010; 68:312-316.
  • 2Meirhaeghe A, Fajas L, Gouilleux F, Cottel D, Helbecque N, Auwerx J, Amouyel P. A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population. Arterioscler Thromb Vasc Biol 2003; 23:289-294.
  • 3Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000; 405:421-424.
  • 4Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz M, Moller DE, Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 1996; 224:431-437.
  • 5Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, Kazumori H, Okuyama T, Rumi MA, Fukuda R, Nagasue N, Kinoshita Y. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists. Br J Cancer 2000; 83:1394-1400.
  • 6Ban JO, Kwak DH, Oh JH, Park EJ, Cho MC, Song HS, Song MJ, Han SB, Moon DC, Kang KW, Hong JT. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Chem Biol Interact 2010; 188:75-85.
  • 7Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002; 20:11-20.
  • 8Scott GA, McClelland LA, Fricke AF, Fender A. Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression. J Invest Dermatol 2009; 129:954-963.
  • 9Suyama E, Wadhwa R, Kawasaki H, Yaguchi T, Kaul SC, Nakajima M, Taira K. LIM kinase-2 targeting as a possible anti-metastasis therapy. J Gene Med 2004; 6:357-363.
  • 10Nishimura Y, Yoshioka K, Bernard O, Bereczky B, Itoh K. A role of LIM kinase 1/cofilin pathway in regulating endocytic trafficking of EGF receptor in human breast cancer cells. Histochem Cell Biol 2006; 126:627-638.

同被引文献94

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部